These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 38161196

  • 1. Targeted co-delivery of FOXM1 aptamer and DOX by nucleolin aptamer-functionalized pH-responsive biocompatible nanodelivery system to enhance therapeutic efficacy against breast cancer: in vitro and in vivo.
    Masoudi M, Taghdisi SM, Hashemitabar G, Abnous K.
    Drug Deliv Transl Res; 2024 Jun; 14(6):1535-1550. PubMed ID: 38161196
    [Abstract] [Full Text] [Related]

  • 2. Co-delivery of doxorubicin and aptamer against Forkhead box M1 using chitosan-gold nanoparticles coated with nucleolin aptamer for synergistic treatment of cancer cells.
    Khademi Z, Lavaee P, Ramezani M, Alibolandi M, Abnous K, Taghdisi SM.
    Carbohydr Polym; 2020 Nov 15; 248():116735. PubMed ID: 32919550
    [Abstract] [Full Text] [Related]

  • 3. FOXM1 Aptamer-Polyethylenimine Nanoplatform Coated With Hyaluronic Acid And AS1411 Aptamer For Dual-Targeted Delivery of Doxorubicin And Synergistic Treatment of Tumor Cells.
    Khademi Z, Yazdi KS, Ramezani M, Alibolandi M, Rezvani SA, Abnous K, Taghdisi SM.
    J Pharm Sci; 2024 Aug 15; 113(8):2198-2207. PubMed ID: 38432623
    [Abstract] [Full Text] [Related]

  • 4. Improving Chemotherapy Effectiveness: Utilizing CuS Nanoparticles Coated with AS1411 Aptamer and Chitosan for Targeted Delivery of Doxorubicin to Cancerous Cells.
    Imanimoghadam M, Yaghoobi E, Alizadeh F, Ramezani M, Alibolandi M, Abnous K, Taghdisi SM.
    J Pharm Sci; 2024 Jul 15; 113(7):1865-1873. PubMed ID: 38342338
    [Abstract] [Full Text] [Related]

  • 5. Synthesis of multimodal polymersomes for targeted drug delivery and MR/fluorescence imaging in metastatic breast cancer model.
    Zavvar T, Babaei M, Abnous K, Taghdisi SM, Nekooei S, Ramezani M, Alibolandi M.
    Int J Pharm; 2020 Mar 30; 578():119091. PubMed ID: 32007591
    [Abstract] [Full Text] [Related]

  • 6. Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers.
    Abnous K, Danesh NM, Ramezani M, Charbgoo F, Bahreyni A, Taghdisi SM.
    Expert Opin Drug Deliv; 2018 Nov 30; 15(11):1045-1052. PubMed ID: 30269603
    [Abstract] [Full Text] [Related]

  • 7. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
    Taghdisi SM, Danesh NM, Ramezani M, Yazdian-Robati R, Abnous K.
    Mol Pharm; 2018 May 07; 15(5):1972-1978. PubMed ID: 29669200
    [Abstract] [Full Text] [Related]

  • 8. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
    Liu J, Wei T, Zhao J, Huang Y, Deng H, Kumar A, Wang C, Liang Z, Ma X, Liang XJ.
    Biomaterials; 2016 Jun 07; 91():44-56. PubMed ID: 26994877
    [Abstract] [Full Text] [Related]

  • 9. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA, Abnous K, Badiee A, Jaafari MR.
    Colloids Surf B Biointerfaces; 2016 Mar 01; 139():228-36. PubMed ID: 26722819
    [Abstract] [Full Text] [Related]

  • 10. Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity.
    Dou XQ, Wang H, Zhang J, Wang F, Xu GL, Xu CC, Xu HH, Xiang SS, Fu J, Song HF.
    Int J Nanomedicine; 2018 Mar 01; 13():763-776. PubMed ID: 29440899
    [Abstract] [Full Text] [Related]

  • 11. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
    Xie X, Li F, Zhang H, Lu Y, Lian S, Lin H, Gao Y, Jia L.
    Eur J Pharm Sci; 2016 Feb 15; 83():28-35. PubMed ID: 26690044
    [Abstract] [Full Text] [Related]

  • 12. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K, Hu X, Shanmugam S, Chelliah R, Sekar P, Oh DH, Vijayakumar S, Kathiresan K, Wang MH.
    Arch Biochem Biophys; 2019 Aug 15; 671():143-151. PubMed ID: 31283911
    [Abstract] [Full Text] [Related]

  • 13. Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells.
    Esawi E, Alshaer W, Mahmoud IS, Alqudah DA, Azab B, Awidi A.
    Int J Mol Sci; 2021 Nov 30; 22(23):. PubMed ID: 34884745
    [Abstract] [Full Text] [Related]

  • 14. Reducing Doxorubicin resistance in breast cancer by liposomal FOXM1 aptamer: In vitro and in vivo.
    Ghandhariyoun N, Jaafari MR, Nikoofal-Sahlabadi S, Taghdisi SM, Moosavian SA.
    Life Sci; 2020 Dec 01; 262():118520. PubMed ID: 33010284
    [Abstract] [Full Text] [Related]

  • 15. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
    Akbarzadeh M, Babaei M, Abnous K, Taghdisi SM, Peivandi MT, Ramezani M, Alibolandi M.
    Int J Pharm; 2019 Oct 30; 570():118645. PubMed ID: 31465835
    [Abstract] [Full Text] [Related]

  • 16. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles.
    Bagheri E, Alibolandi M, Abnous K, Taghdisi SM, Ramezani M.
    J Mater Chem B; 2021 Feb 15; 9(5):1351-1363. PubMed ID: 33447840
    [Abstract] [Full Text] [Related]

  • 17. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
    Mosafer J, Mokhtarzadeh A.
    Curr Drug Deliv; 2018 Feb 15; 15(9):1323-1329. PubMed ID: 30039760
    [Abstract] [Full Text] [Related]

  • 18. pH-controlled nucleolin targeted release of dual drug from chitosan-gold based aptamer functionalized nano drug delivery system for improved glioblastoma treatment.
    Sathiyaseelan A, Saravanakumar K, Mariadoss AVA, Wang MH.
    Carbohydr Polym; 2021 Jun 15; 262():117907. PubMed ID: 33838795
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment.
    Liang X, Wang Y, Shi H, Dong M, Han H, Li Q.
    Int J Nanomedicine; 2021 Jun 15; 16():2569-2584. PubMed ID: 33833512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.